← All trials
NCT06616584
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 11, 2025
- Primary completion
- Dec 31, 2027
- Completion date
- Dec 31, 2028
- First posted
- Sep 27, 2024
- Last posted
- Sep 27, 2024
- Enrollment
- 378
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- SWOG Cancer Research NetworkLead sponsor
- RegeneronCollaborator
- SWOG Cancer Research NetworkOfficial
- National Cancer Institute (NCI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.